Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumorsDavid H. Henry, Howard Yeh, Saroj Vadhan‐Raj et al.|Supportive Care in Cancer|2013Cited by 182
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II studyJavier Martín‐Broto, C. Atchison, Martin Dominkus et al.|Acta Oncologica|2014Cited by 69
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Bruce Allen Bach, Leanne L. Seeger et al.|World Journal of Surgical Oncology|2018Cited by 56
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseIngo Diel, Ada Braun, Jean‐Jacques Body et al.|European Journal of Cancer|2015Cited by 53